ALC:NYSE
Alcon AG
$74.11
arrow_upward
+0.64%(+0.47) 1D
$74.98
arrow_upward
+1.17% (+0.87)bedtimeAfter hours
Closed: Nov 17, 4:00:03 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALC...
Open
$73.40
High
$74.54
Low
$73.36
Mkt. cap
30.88B
Avg. vol.
2.15M
Volume
4.80M
52-wk high
$87.64
52-wk low
$61.84
Beta
0.87
Shares outstanding
483.40M
No. of employees
25K
Open
$73.40
High
$74.54
Low
$73.36
Mkt. cap
30.88B
Avg. vol.
2.15M
Volume
4.80M
52-wk high
$87.64
52-wk low
$61.84
Beta
0.87
Shares outstanding
483.40M
No. of employees
25K
News stories
From web sources and news partners
BigGo Finance
·
7 hours ago
New York Stocks Fall for Fourth Straight Session Ahead of Nvidia Earnings; Dow Plunges 1.6%
ChartMill
·
8 hours ago
S&P 500 After-Hours Gainers for Nov. 17, 2026
Fox Business
·
10 hours ago
S&P 500 decline driven by semiconductor confidence issues, says Scott Chronert
Traders Union
·
4 hours ago
S&P 500 rises 10 percent amid challenging backdrop, Nate Geraci notes
Profile
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
About Alcon AG
CEODavid J. Endicott
Employees25K
Founded1945
HeadquartersGeneva, Geneva, Switzerland
SectorHealth Care
IndustryMedical device
Websitealcon.com